// App-Quantinova.ai

P54 : Development of ocular toxoplasmosis and panuveitis in a patient receiving infliximab for psoriatic arthritis

Researchers

Presenter

  • Mariam Malik

Principal Investigators

  • Himashi Anver

  • Ernest Wong

Medical Centers

  • Southampton General Hospital, NHS, Rheumatology, Southampton, UNITED KINGDOM

  • Poole Hospital, NHS, Rheumatology, Poole, UNITED KINGDOM

  • Queen Alexandra Hospital, NHS, Rheumatology, Portsmouth, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Psoriatic arthritis

  • Visual dysfunction

  • Inflammatory Arthritis

  • Hepatitis B

Biomarkers

  • N/A

Drug/Treatment

  • Sulfasalazine

  • Azithromycin

  • Methotrexate

  • Prednisolone

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A